Literature DB >> 12088302

Current perspectives on pain in AIDS.

William Breitbart1, Lucia Dibiase.   

Abstract

As active participants in the care of patients with acquired immunodeficiency syndrome (AIDS), oncologists need to be aware of the many facets of pain management in this population. This two-part article, which will conclude in the July 2002 issue, describes the prevalence and types of pain syndromes encountered in patients with AIDS, and reviews the psychological and functional impact of pain as well as the barriers to adequate pain treatment in this group and others with human immunodeficiency virus (HIV)-related disease. Finally, principles of pain management, with particular emphasis on controlling pain in HIV-infected patients with a history of substance abuse, are outlined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088302

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

1.  Opioids and HIV Infection: From Pain Management to Addiction Treatment.

Authors:  Chinazo O Cunningham
Journal:  Top Antivir Med       Date:  2018-04

2.  Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Authors:  Sylvia Fitting; David L Stevens; Fayez A Khan; Krista L Scoggins; Rachel M Enga; Patrick M Beardsley; Pamela E Knapp; William L Dewey; Kurt F Hauser
Journal:  J Pharmacol Exp Ther       Date:  2015-11-05       Impact factor: 4.030

3.  Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain.

Authors:  Xianxun Chi; Tohti Amet; Daniel Byrd; Kuei-Hua Chang; Kavita Shah; Ningjie Hu; Ayslinn Grantham; Sishun Hu; Jianhong Duan; Feng Tao; Grant Nicol; Qigui Yu
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

4.  Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model.

Authors:  Chun-Su Yuan; Chong-Zhi Wang; Sangeeta R Mehendale; Han H Aung; Adela Foo; Robert J Israel
Journal:  AIDS Res Ther       Date:  2009-08-21       Impact factor: 2.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.